Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
The S&P 500 index fund offers wide exposure to major US companies with low costs. This intro covers benefits and considerations for beginners.
22,408 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
A major investor disclosed a $46 million stake in a Goldman Sachs BDC, signaling selective confidence in a sector fac...
AT&T has been through a long turnaround, shedding assets and tightening the balance sheet. This article weighs the ca...
A Virginia federal judge denied Zillow and Redfin’s bid to dismiss the FTC antitrust lawsuit, keeping the case alive ...
XRP jumps above $1.45 on strong Upbit demand in South Korea, with institutional buying and tokenized treasuries suppo...
Trump heads to Beijing for a high-stakes meeting with Xi Jinping, as AI chip controls and farm trade take center stag...
Wells Fargo lifts its NVIDIA price target to $315 ahead of the May earnings release, maintaining an Overweight rating...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
SpaceX could become one of the biggest IPOs in history. This guide breaks down what to watch, what it means for your ...
SoundHound AI has delivered notable revenue gains, even as its stock retreated. This article breaks down what's drivi...
Nexxn (NEXN) 2026 earnings signal how the company is navigating growth, profitability, and capital allocation. This g...
A new forecast from microsoft leading copilot predicts XRP could reach as high as $15 by end-2026 if regulatory clari...